Home › Funds › Man Group plc › ONC
Man Group plc position in ONC
BEONE MEDICINES LTD · Health Care
Man Group plc reported holding 492,820 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$180.3M, representing 0.46% of its reported portfolio and ranking #40 among its reported holdings. Man Group plc has disclosed ONC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Man Group plc's ONC position evolved
Man Group plc first disclosed a stake in ONC in Q4 2023 at 41,143 shares (US$7.4M). The position peaked in Q3 2026 at 492,820 shares, worth US$180.3M. Across 12 filings, Man Group plc increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 492,820 shares valued at US$180.3M — an increase of 185,357 shares quarter over quarter.. Notable position changes include a 731% increase in Q3 2024 (shares fell 18% over the following quarter), a 87% trim in Q4 2024 (shares rose 47% over the following quarter), a 1504% increase in Q1 2025 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 41.14K | $7.42M | New |
| Q1 2024 | 6.83K | $1.07M | Reduce |
| Q2 2024 | 9.18K | $1.31M | Add |
| Q3 2024 | 76.23K | $17.11M | Add |
| Q4 2024 | 9.59K | $1.77M | Reduce |
| Q1 2025 | 153.82K | $41.87M | Add |
| Q2 2025 | 243.86K | $59.03M | Add |
| Q3 2025 | 209.02K | $71.21M | Reduce |
| Q4 2025 | 248.51K | $75.50M | Add |
| Q1 2026 | 241.92K | $71.84M | Reduce |
| Q2 2026 | 307.46K | $87.62M | Add |
| Q3 2026 | 492.82K | $180.34M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 31 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$3.23B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.83M sh · $3.23B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 4.91M sh · $1.80B · Q3 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Two Sigma Investments 656.71K sh · $240.31M · Q3 2026
- Siren, L.L.C. 465.00K sh · $170.16M · Q3 2026
- Candriam S.C.A. 289.24K sh · $106.23M · Q3 2026
- Capital International, Inc./CA/ 290.16K sh · $106.18M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 240.59K sh · $88.04M · Q3 2026
- Capital International Sarl 206.19K sh · $75.45M · Q3 2026
More on Man Group plc
FAQ
How long has Man Group plc held ONC?
Man Group plc has disclosed ONC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Man Group plc's current position in ONC?
As of Q3 2026, Man Group plc holds 492.82K shares of ONC (BEONE MEDICINES LTD), valued at $180.34M, representing 0.46% of its reported portfolio and ranking #40.
Has Man Group plc been buying or selling ONC?
In the latest 13F filing (Q3 2026), Man Group plc increased its position in ONC. The position peaked in Q3 2026 at 492.82K shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.